These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23302066)

  • 1. Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes.
    Aoki A; Murata M; Asano T; Ikoma A; Sasaki M; Saito T; Otani T; Jinbo S; Ikeda N; Kawakami M; Ishikawa SE
    Cardiovasc Diabetol; 2013 Jan; 12():11. PubMed ID: 23302066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
    Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
    Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes.
    Maser RE; Lenhard MJ; Sneider MB; Pohlig RT
    Endocr Pract; 2015 Jan; 21(1):14-22. PubMed ID: 25100392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis.
    Ramirez-Sandoval JC; Casanova I; Villar A; Gomez FE; Cruz C; Correa-Rotter R
    Perit Dial Int; 2016; 36(3):262-8. PubMed ID: 26293840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S; Sobh R
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin Is the Strongest Predictor for Progression of Arterial Calcification in Peritoneal Dialysis Patients.
    Avila M; Mora C; Prado MDC; Zavala M; Paniagua R;
    Am J Nephrol; 2017; 46(1):39-46. PubMed ID: 28614819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients.
    Li G; Lu WH; Ai R; Yang JH; Chen F; Tang ZZ
    Cardiovasc Diabetol; 2014 Feb; 13():52. PubMed ID: 24564828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients.
    Ozkok A; Caliskan Y; Sakaci T; Erten G; Karahan G; Ozel A; Unsal A; Yildiz A
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):965-73. PubMed ID: 22490874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors Associated With Altered Circulating Micro RNA -125b and Their Influences on Uremic Vascular Calcification Among Patients With End-Stage Renal Disease.
    Chao CT; Yuan TH; Yeh HY; Chen HY; Huang JW; Chen HW
    J Am Heart Assoc; 2019 Jan; 8(2):e010805. PubMed ID: 30646802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor κB ligand, osteoprotegerin, and neuropathy.
    Bourron O; Aubert CE; Liabeuf S; Cluzel P; Lajat-Kiss F; Dadon M; Komajda M; Mentaverri R; Brazier M; Pierucci A; Morel F; Jacqueminet S; Massy ZA; Hartemann A
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4250-8. PubMed ID: 25013993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.
    Giovannini S; Tinelli G; Biscetti F; Straface G; Angelini F; Pitocco D; Mucci L; Landolfi R; Flex A
    Cardiovasc Diabetol; 2017 Aug; 16(1):99. PubMed ID: 28789654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse regulation of serum osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand levels in patients with leg lesional vascular calcification: An observational study.
    Moon AR; Park Y; Chang JH; Lee SS
    Medicine (Baltimore); 2019 Mar; 98(10):e14489. PubMed ID: 30855435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
    Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
    Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
    Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
    Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus.
    Tavintharan S; Pek LT; Liu JJ; Ng XW; Yeoh LY; Su Chi L; Chee Fang S
    Diab Vasc Dis Res; 2014 Sep; 11(5):359-62. PubMed ID: 25005034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes confers
    Patidar A; Singh DK; Thakur S; Winocour P; Farrington K; Baydoun AR
    Clin Sci (Lond); 2017 May; 131(10):991-1000. PubMed ID: 28320782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study.
    Schoppet M; Hofbauer LC; Brinskelle-Schmal N; Varennes A; Goudable J; Richard M; Hawa G; Chapurlat R; Szulc P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E575-83. PubMed ID: 22319041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 inhibits osteoblastic gene expression and induces osteoprotegerin in vascular smooth muscle cells.
    Nakahara T; Kawai-Kowase K; Matsui H; Sunaga H; Utsugi T; Iso T; Arai M; Tomono S; Kurabayashi M
    Atherosclerosis; 2016 Oct; 253():102-110. PubMed ID: 27599364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus.
    Demková K; Kozárová M; Malachovská Z; Javorský M; Tkáč I
    Vasa; 2018 Feb; 47(2):131-135. PubMed ID: 29313442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular calcification biomarkers and peripheral arterial disease.
    Kapetanios D; Karkos C; Giagtzidis I; Papazoglou K; Kiroplastis K; Spyridis C
    Int Angiol; 2016 Oct; 35(5):455-9. PubMed ID: 26044839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.